Table 1.
Baseline characteristics of subjects with T1DM in Intervention (P-CGM+SMBG) and Control (SMBG only) groups.
| S.No | Baseline Parameters | P-CGM + SMBG n = 30 | SMBG alone n = 33 | P value | |
|---|---|---|---|---|---|
| 1. | Age (months) Mean ± SD | 70.02 ± 25.30 | 75.26 ± 25.30 | 0.443 | |
| 2. | Gender | Male | 15 (50%) | 19 (57.6%) | 0.547 |
| Female | 15 (50%) | 14 (42.4%) | |||
| 3. | Duration of Diabetes (months) Median (IQR) | 12 (8.5–24.25) | 11 (6–22.5) | 0.544* | |
| 4. | Average HbA1c (6 months) (%) (mmol/mol) | 8.01 ± 1.46 (64 ± 2.9) |
7.86 ± 1.18 (62.4 ± 2.1) |
0.673 | |
| 5. | Total insulin dose (U/Kg/Day) | 1.12 ± 0.36 | 1.07 ± 0.38 | 0.627 | |
| 6. | Percentage Hyperglycemic records# | 21.82 ± 14.13 | 21.88 ± 16.36 | 0.989 | |
| 7. | Percentage Hypoglycemic records# | 7.88 ± 6.45 | 7.93 ± 5.32 | 0.690 | |
| 8. | Anti-GAD 65 Antibody Positive | 4 (13.3%) | 9 (27.3%) | 0.172 | |
*Mann Whitney U test; #Calculated from SMBG records of previous 3 months.